J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer

Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer. The pharmaceutical giant announced the deal on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country.
Reported by 2 outlets — Al Jazeera, Investing.com · Stock Market. See all sources ↓
Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer. The pharmaceutical giant announced the deal on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country. Talc is a soft mineral and was once a staple ingredient in cosmetics and baby products, but its use has declined as concerns rose over its links to cancer. In 2024, the World Health Organization classified talc as “probably carcinogenic to humans”.
Read the full report at Al Jazeera ↗
Why it matters
2 outlets are covering this world story — one to watch as reporting develops.
- What's the story?
- Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer. The pharmaceutical giant announced the deal on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country.
- How widely is it covered?
- 2 outlets, average source rating 6.5/10.
- When was it last updated?
- 6m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card2 outlets1CoverageScouting report
Johnson & Johnson to pay $5.5 bln to settle talc-related cancer lawsuits
Sources2TypeCoverageAl Jazeera
Investing.com · Stock Market